FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SterRx Succinylcholine Chloride Injection Recall

Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, Rx only,…

SterRx, LLC · Plattsburgh, NY

Risk level
Class II
Reported by FDA
Jan 5, 2022
Recall ID
D-0307-2022
Check your lot numberHow we source this data

Summary

SterRx recalled Succinylcholine Chloride Injection starting Nov 12, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0307-2022 on Jan 5, 2022. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-826-01.

Lot numbers, UPCs & expiration codes

S21367/CBA 18-Nov-21 S21403/CCL 9-Dec-21

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0307-2022
Classification
Class II
Status
Terminated
Recall initiated
Nov 12, 2021
FDA report date
Jan 5, 2022
Quantity
3540 bags
Recall type
Voluntary: Firm initiated
Recalling firm
SterRx, LLC

Original FDA data

Every field from FDA enforcement report D-0307-2022, exactly as published.

Show all FDA fields
City
Plattsburgh
State
NY
Status
Terminated
Country
United States
Event ID
89059
Address
141 Idaho Ave
Code information
S21367/CBA 18-Nov-21 S21403/CCL 9-Dec-21
Postal code
12903-3987
Report date
Jan 5, 2022
Product type
Drugs
Recall number
D-0307-2022
Classification
Class II
Recalling firm
SterRx, LLC
Product quantity
3540 bags
Termination date
Dec 6, 2023
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-826-01.
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Nov 12, 2021
Initial firm notification
Press Release
Center classification date
Dec 29, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0307-2022, published Jan 5, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls